Jeffrey M. Holzbeierlein
Expertise in
22
conditions

Dr. Jeffrey M. Holzbeierlein

Oncology
2000 Olathe Boulevard, 
Kansas City, KS 
Accepting New Patients
Offers Telehealth
Expertise in
22
conditions
2000 Olathe Boulevard, 
Kansas City, KS 

Overview

Jeffrey Holzbeierlein is an Oncologist practicing medicine in Kansas City, Kansas.

Dr. Holzbeierlein is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Holzbeierlein is board certified in American Board Of Urology, Urology - 2004. He is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials. Dr. Holzbeierlein is currently accepting new patients.

Specialties

Oncology

Licenses

Urology in KS

Board Certifications

American Board Of Urology, Urology - 2004

Fellowships

Memorial Sloan Kettering Cancer Center, Urologic Oncology, 2002

Hospital Affiliations

University Of Kansas Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Medical Pavilion
2000 Olathe Boulevard, Kansas City, KS 66160
Other Locations
The University of Kansas Hospital
4000 Cambridge Street, Kansas City, KS 66160
Westwood Medical Pavilion
2650 Shawnee Mission Parkway, Westwood, KS 66205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 31, 2026
Intervention Type: Biological
Study Drugs: Bacillus of Calmette-Guerin, ALT-803
Study Phase: Phase 1/Phase 2
Application-based Perioperative Management of the Radical Cystectomy Patient
Application-based Perioperative Management of the Radical Cystectomy Patient
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Other
Study Phase: Not Applicable
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Enrollment Status: Completed
Publish Date: August 22, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

100 Total Publications

2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.
2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.
Journal: The Journal of urology
Published: September 03, 2026
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

The University Of Kansas Hospital

4000 Cambridge Street, 
Kansas City, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English, Korean
See accepted insurances
Accepting New Patients
Offers Telehealth

Eugene Lee is an Oncologist practicing medicine in Kansas City, Kansas. Dr. Lee is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Lee is board certified in American Board Of Urology, Urology - 2015. Dr. Lee is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Saint Luke's Cancer Specialists-Plaza

4401 Wornall Rd, 
Kansas City, MO 
 (1.1 miles away)
816-932-3300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samuel Goldlust is an Oncologist practicing medicine in Kansas City, Missouri. Dr. Goldlust is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Goldlust is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
 (2.4 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tara Lin is an Oncologist practicing medicine in Fairway, Kansas. Dr. Lin is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Colonoscopy. Dr. Lin is board certified in American Board Of Internal Medicine, Medical Oncology - 2005. Dr. Lin is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey M. Holzbeierlein

How do I make an appointment with Dr. Jeffrey M. Holzbeierlein?

You can book an appointment with Dr. Jeffrey M. Holzbeierlein by calling their office at 913-588-1227. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey M. Holzbeierlein a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey M. Holzbeierlein is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey M. Holzbeierlein specialize in?

While Dr. Jeffrey M. Holzbeierlein is a Oncology, they have specific expertise in Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jeffrey M. Holzbeierlein participate in research or clinical trials?

Yes. Dr. Jeffrey M. Holzbeierlein has published 100 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Jeffrey M. Holzbeierlein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey M. Holzbeierlein accept my insurance?

Dr. Jeffrey M. Holzbeierlein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 913-588-1227 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Holzbeierlein's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 7 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile